Fig. 3From: Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK2140944)Changes in specific microbiota genera at Day 5 and Follow-up compared to Day 1 for the (A) gastro-intestinal tract (GIT); (B) pharyngeal cavity and (C) vagina. Size represents -log10 of FDR-adjusted P-value and lines represent CI at 95%Back to article page